<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="review-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2024-024</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-8106</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ШКОЛА ПЕДИАТРА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PEDIATRICIAN SCHOOL</subject></subj-group></article-categories><title-group><article-title>Наследственные периодические лихорадки у детей</article-title><trans-title-group xml:lang="en"><trans-title>Hereditary periodic fevers in children</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7516-5756</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Крутихина</surname><given-names>С. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Krutikhina</surname><given-names>S. B. </given-names></name></name-alternatives><bio xml:lang="ru"><p>Крутихина Светлана Борисовна, к.м.н., ассистент кафедры детских болезней Клинического института детского здоровья имени Н.Ф. Филатова</p><p>119991, Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Svetlana B. Krutikhina, Cand. Sci. (Med.), Assistant at the Department of Pediatric Diseases of the N.F. Filatov Clinical Institute of Child Health</p><p>8, Bldg. 2, Trubetskaya St., Moscow, 119991</p></bio><email xlink:type="simple">svetulkakru@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7275-4344</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кудряшова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kudryashova</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кудряшова Мария Алексеевна, к.м.н., ассистент кафедры детских болезней Клинического института детского здоровья имени Н.Ф. Филатова</p><p>119991, Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Mariya A. Kudryashova, Cand. Sci. (Med.), Assistant at the Department of Pediatric Diseases of the N.F. Filatov Clinical Institute of Child Health</p><p>8, Bldg. 2, Trubetskaya St., Moscow, 119991</p><p>   </p></bio><email xlink:type="simple">xvosel@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Первый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет)<country>Россия</country></aff><aff xml:lang="en">Sechenov First Moscow State Medical University (Sechenov University)<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>02</month><year>2024</year></pub-date><volume>0</volume><issue>1</issue><elocation-id>276–280</elocation-id><permissions><copyright-statement>Copyright &amp;#x00A9; Крутихина С.Б., Кудряшова М.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Крутихина С.Б., Кудряшова М.А.</copyright-holder><copyright-holder xml:lang="en">Krutikhina S.B., Kudryashova M.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/8106">https://www.med-sovet.pro/jour/article/view/8106</self-uri><abstract><p>Лихорадочные состояния у детей – актуальная проблема в педиатрии, т. к. они являются одним из частых симптомов по обращению за медицинской помощью. Аутовоспалительные заболевания (АВЗ) представляют из себя группу заболеваний, при которых лихорадка является одним из основных симптомов, отмечается определенная периодичность и длительность приступа. В основе аутовоспалительных заболеваний лежит развитие системного асептического воспаления, связанного с активацией врожденного иммунитета, при этом не отмечается повышения уровня аутоантител. Среди аутовоспалительных заболеваний самыми распространенными являются наследственные периодические лихорадки, к которым относятся семейная средиземноморская лихорадка (ССЛ), Hyper- Immunoglobulinemia D-syndrome / Mevalonate Kinasae Deficiency syndrome (HIDS/MKD), CAPS-, Tumor necrosis factor receptor-associated periodic syndrome (TRAPS)-синдромы и более редкие заболевания (дефицит естественных антагонистов рецепторов интерлейкинов). В основе патогенеза данной группы заболеваний лежит процесс ускоренного формирования супрамолекулярного белкового комплекса (инфламмасомы), что в дальнейшем приводит к переходу неактивной формы ИЛ1β в его активную форму. Клиническая картина данных заболеваний может быть сходна, включает в себя эпизоды лихорадки, боли в животе, артралгии, различные сыпи и др., повышение острофазовых показателей. Для данных заболеваний характерна определенная периодичность появления симптомов, обычно имеются промежутки без наличия симптоматики. Для семейной средиземноморской лихорадки характерна определенная этническая принадлежность (армяне, турки, арабы, евреи). Наиболее точным методом диагностики семейной средиземноморской лихорадки на сегодняшний день является молекулярно-генетическое исследование. Современная терапия направлена на профилактику приступов заболевания, но также важно использовать симптоматическую терапию для облегчения состояния ребенка при уже развившемся приступе. Современные подходы терапии включают как препараты, давно использующиеся в педиатрической практике (колхицин, нестероидные противовоспалительные препараты (ибупрофен), глюкокортикостероиды), так и «новые» генно-инженерные биологические препараты (блокаторы интерлейкинов, фактора некроза опухолей и др.).</p></abstract><trans-abstract xml:lang="en"><p>Fevers in children is a pressing challenge in paediatrics, as they are one of the most common symptoms people seek medical help. Autoinflammatory diseases (AIDs) constitute a group of diseases, where fever is one of the main symptoms, and fever attacks have a certain frequency and duration. Autoinflammatory diseases are rooted in the systemic aseptic inflammation associated with activation of the innate immune system, without elevated levels of autoantibodies. The most common autoinflammatory diseases include hereditary periodic fevers, among which are familial Mediterranean fever (FMF), HIDS/MKD, CAPS-, TRAPS-syndromes and rarer diseases (deficiency of natural interleukin receptor antagonists). The pathogenesis of this group of diseases is based on the process of accelerated formation of a supramolecular protein complex (inflammasome), which subsequently leads to the transition of the inactive form of IL1β into its active form. The clinical presentations of these diseases may be similar and include episodes of fever, abdominal pain, arthralgia, various rashes, etc., as well as an increase in acute phase parameters. These diseases are characterized by symptoms at certain intervals; they usually have intervals without showing any symptoms. Familial Mediterranean fever is characterized by a certain ethnic background (Armenians, Turks, Arabs, Jews). Today, molecular genetic testing is the most accurate method for diagnosing familial Mediterranean fever. Current therapy aims to prevent attacks of the disease, but it is also important to use symptomatic therapy to relieve the child’s condition when an attack has already developed. Modern treatment strategies include both drugs that have long been used in paediatric practice (colchicine, non-steroidal anti-inflammatory drugs (ibuprofen), glucocorticosteroids) and novel genetically engineered biological drugs (interleukin antagonists and tumour necrosis factor inhibitors, etc.).</p></trans-abstract><kwd-group xml:lang="ru"><kwd>лихорадка</kwd><kwd>ибупрофен</kwd><kwd>аутовоспалительные заболевания</kwd><kwd>семейная средиземноморская лихорадка</kwd><kwd>HIDS</kwd><kwd>MKD</kwd><kwd>CAPS</kwd><kwd>TRAPS</kwd></kwd-group><kwd-group xml:lang="en"><kwd>fever</kwd><kwd>ibuprofen</kwd><kwd>auto-inflammatory diseases</kwd><kwd>family mediterranean fever</kwd><kwd>HIDS</kwd><kwd>MKD</kwd><kwd>CAPS</kwd><kwd>TRAPS</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Захарова ИН, Османов ИМ, Творогова ТМ, Горяйнова АН, Дмитриева ЮА, Воробьева АС, Короид НВ. Длительная лихорадка у ребенка: в чем причина, как обследовать, лечить или не лечить? Медицинский совет. 2020;(10):151–162. https://doi.org/10.21518/2079-701X-2020-10-151-162.</mixed-citation><mixed-citation xml:lang="en">Zakharova IN, Osmanov IM, Tvorogova TM, Goryainova AN, Dmitrieva YuA, Vorobyeva AS, Koroid NV. Long-term fever in a child: what is the reason, how to examine, treat or not treat? Meditsinskiy Sovet. 2020;(10):151–162. (In Russ.) https://doi.org/10.21518/2079-701X-2020-10-151-162.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Сомова ТМ. Аутовоспалительное заболевание – синдром гипериммуноглобулинемии D. Медицинский вестник Юга России. 2022;13(2):141–145. https://doi.org/10.21886/2219-8075-2022-13-2-141-145</mixed-citation><mixed-citation xml:lang="en">Somova TM. Autoinflammatory disease – syndrome of hyperimmunoglobulinemia D. Medical Herald of the South of Russia. 2022;13(2):141–145. (In Russ.) https://doi.org/10.21886/2219-8075-2022-13-2-141-145.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Салугина СО, Федоров ЕС, Агафонова ЕМ. Моногенные аутовоспалительные заболевания у детей и взрослых: что необходимо знать ревматологу. Научно-практическая ревматология. 2019;57(2):125–132. https://doi.org/10.14412/1995-4484-2019-125-132.</mixed-citation><mixed-citation xml:lang="en">Salugina SO, Fedorov ES, Agafonova EM. Monogenic auto-inflammatory diseases in children and adults: what a rheumatologist should know. Rheumatology Science and Practice. 2019;57(2):125–132. (In Russ.) https://doi.org/10.14412/1995-4484-2019-125-132.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Гатторно М. Аутовоспалительные заболевания у детей. Вопросы современной педиатрии. 2014;13(2):55–64. https://doi.org/10.14412/1995-4484-2019-125-132.</mixed-citation><mixed-citation xml:lang="en">Gattorno M. Autoinflammatory diseases in children. Current Pediatrics. 2014;13(2):55–64. (In Russ.) https://doi.org/10.14412/1995-4484-2019-125-132.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Крутихина СБ, Горелов АВ, Яблокова ЕА, Тюрина ЕН, Мелешкина АВ, Чебышева СН, Савватеева ОА. Семейная средиземноморская лихорадка у детей: современные методы диагностики и подходы к терапии болевого абдоминального синдрома. Вопросы детской диетологии. 2021;19(2):76–82. https://doi.org/10.20953/1727-5784-2021-2-76-82.</mixed-citation><mixed-citation xml:lang="en">Krutikhina SB, Gorelov AV, Yablokova EA, Tyurina EN, Meleshkina AV, Chebysheva SN, Savvateeva OA. Familial mediterranean fever in children: modern methods of diagnosis and approaches to the treatment of abdominal pain syndrome. Pediatric Nutrition. 2021;19(2):76–82. (In Russ.) https://doi.org/10.20953/1727-5784-2021-2-76-82.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lancieri M, Bustaffa M, Palmeri S, Prigione I, Penco F, Papa R et al. An Update on Familial Mediterranean Fever. Int J Mol Sci. 2023;24(11):9584. https://doi.org/10.3390/ijms24119584.</mixed-citation><mixed-citation xml:lang="en">Lancieri M, Bustaffa M, Palmeri S, Prigione I, Penco F, Papa R et al. An Update on Familial Mediterranean Fever. Int J Mol Sci. 2023;24(11):9584. https://doi.org/10.3390/ijms24119584.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Diaz A, Hu C, Kastner DL, Schaner P, Reginato AM, Richards N, Gumucio DL. Lipopolysaccharide-Induced Expression of Multiple Alternatively Spliced MEFV Transcripts in Human Synovial Fibroblasts: A Prominent Splice Isoform Lacks the C-Terminal Domain That Is Highly Mutated in Familial Mediterranean Fever. Arthritis Rheum. 2004;50(11):3679–3689. https://doi.org/10.1002/art.20600.</mixed-citation><mixed-citation xml:lang="en">Diaz A, Hu C, Kastner DL, Schaner P, Reginato AM, Richards N, Gumucio DL. Lipopolysaccharide-Induced Expression of Multiple Alternatively Spliced MEFV Transcripts in Human Synovial Fibroblasts: A Prominent Splice Isoform Lacks the C-Terminal Domain That Is Highly Mutated in Familial Mediterranean Fever. Arthritis Rheum. 2004;50(11):3679–3689. https://doi.org/10.1002/art.20600.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zadeh N, Getzug T, Grody WW. Diagnosis and Management of Familial Mediterranean Fever: Integrating Medical Genetics in a Dedicated Interdisciplinary Clinic. Genet Med. 2011;13(3):263–269. https://doi.org/10.1097/GIM.0b013e31820e27b1.</mixed-citation><mixed-citation xml:lang="en">Zadeh N, Getzug T, Grody WW. Diagnosis and Management of Familial Mediterranean Fever: Integrating Medical Genetics in a Dedicated Interdisciplinary Clinic. Genet Med. 2011;13(3):263–269. https://doi.org/10.1097/GIM.0b013e31820e27b1.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Di Donato G, d’Angelo DM, Breda L, Chiarelli F. Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives. Int J Mol Sci. 2021;22(12):6360. https://doi.org/10.3390/ijms22126360.</mixed-citation><mixed-citation xml:lang="en">Di Donato G, d’Angelo DM, Breda L, Chiarelli F. Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives. Int J Mol Sci. 2021;22(12):6360. https://doi.org/10.3390/ijms22126360.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang S. Natural history of mevalonate kinase deficiency: a literature review. Pediatr Rheumatol Online J. 2016;14(1):30. https://doi.org/10.1186/s12969-016-0091-7.</mixed-citation><mixed-citation xml:lang="en">Zhang S. Natural history of mevalonate kinase deficiency: a literature review. Pediatr Rheumatol Online J. 2016;14(1):30. https://doi.org/10.1186/s12969-016-0091-7.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Федоров ЕС, Салугина СО, Соболева МК. Семейный случай TRAPS-синдрома в российской популяции. Современная ревматология. 2015;9(1):60–65. https://doi.org/10.14412/1996-7012-2015-1-60-65.</mixed-citation><mixed-citation xml:lang="en">Fedorov ES, Salugina SO, Soboleva MK. A familial case of TRAPS in a Russian population. Sovremennaya Revmatologiya. 2015;9(1):60–65. (In Russ.) https://doi.org/10.14412/1996-7012-2015-1-60-65.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Shu Z, Zhang Y, Han T, Li Y, Piao Y, Sun F et al. The genetic and clinical characteristics and effects of Canakinumab on cryopyrin-associated periodic syndrome: a large pediatric cohort study from China. Front Immunol. 2023;14:1267933. https://doi.org/10.3389/fimmu.2023.1267933.</mixed-citation><mixed-citation xml:lang="en">Shu Z, Zhang Y, Han T, Li Y, Piao Y, Sun F et al. The genetic and clinical characteristics and effects of Canakinumab on cryopyrin-associated periodic syndrome: a large pediatric cohort study from China. Front Immunol. 2023;14:1267933. https://doi.org/10.3389/fimmu.2023.1267933.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ter Haar N, Lachmann H, Ozen S, Woo P, Uziel Y, Modesto C et al. Treatment of autoinflammatory diseases: results from the eurofever registry and a literature review. Ann Rheum Dis. 2013;72(5):678–685. https://doi.org/10.1136/annrheumdis-2011-201268.</mixed-citation><mixed-citation xml:lang="en">Ter Haar N, Lachmann H, Ozen S, Woo P, Uziel Y, Modesto C et al. Treatment of autoinflammatory diseases: results from the eurofever registry and a literature review. Ann Rheum Dis. 2013;72(5):678–685. https://doi.org/10.1136/annrheumdis-2011-201268.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G et al. EULAR recommendations for the management of familial mediterranean fever. Ann Rheum Dis. 2016;75(4):644–651. https://doi.org/10.1136/annrheumdis-2015-208690.</mixed-citation><mixed-citation xml:lang="en">Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G et al. EULAR recommendations for the management of familial mediterranean fever. Ann Rheum Dis. 2016;75(4):644–651. https://doi.org/10.1136/annrheumdis-2015-208690.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Stahl S, Graslund T, Eriksson Karlstrom A, Frejd FY, Nygren PA, Lofblom J. Affibody molecules in biotechnological and medical applications. Trends Biotechnol. 2017;35(8):691–712. https://doi.org/10.1016/j.tibtech.2017.04.007.</mixed-citation><mixed-citation xml:lang="en">Stahl S, Graslund T, Eriksson Karlstrom A, Frejd FY, Nygren PA, Lofblom J. Affibody molecules in biotechnological and medical applications. Trends Biotechnol. 2017;35(8):691–712. https://doi.org/10.1016/j.tibtech.2017.04.007.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kullenberg T, Lofqvist M, Leinonen M, Goldbach-Mansky R, Olivecrona H. Long-term safety profile of anakinra in patients with severe cryopyrinassociated periodic syndromes. Rheumatology (Oxford). 2016;55(8):1499–1506. https://doi.org/10.1093/rheumatology/kew208.</mixed-citation><mixed-citation xml:lang="en">Kullenberg T, Lofqvist M, Leinonen M, Goldbach-Mansky R, Olivecrona H. Long-term safety profile of anakinra in patients with severe cryopyrinassociated periodic syndromes. Rheumatology (Oxford). 2016;55(8):1499–1506. https://doi.org/10.1093/rheumatology/kew208.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ozen S, Kuemmerle-Deschner JB, Cimaz R, Livneh A, Quartier P, Kone-Paut I et al. International retrospective chart review of treatment patterns in severe FMF, TRAPS and MKD/HIDS. Arthritis Care Res (Hoboken). 2017;69(4):578–586. https://doi.org/10.1002/acr.23120.</mixed-citation><mixed-citation xml:lang="en">Ozen S, Kuemmerle-Deschner JB, Cimaz R, Livneh A, Quartier P, Kone-Paut I et al. International retrospective chart review of treatment patterns in severe FMF, TRAPS and MKD/HIDS. Arthritis Care Res (Hoboken). 2017;69(4):578–586. https://doi.org/10.1002/acr.23120.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Nedjai B, Quillinan N, Coughlan RJ, Church L, McDermott MF, Hitman GA et al. Lessons from anti-TNF biologics: infliximab failure in a TRAPS family with the T50M mutation in TNFRSF1A. Adv Exp Med Biol. 2011;691:409–419. https://doi.org/10.1007/978-1-4419-6612-4_43.</mixed-citation><mixed-citation xml:lang="en">Nedjai B, Quillinan N, Coughlan RJ, Church L, McDermott MF, Hitman GA et al. Lessons from anti-TNF biologics: infliximab failure in a TRAPS family with the T50M mutation in TNFRSF1A. Adv Exp Med Biol. 2011;691:409–419. https://doi.org/10.1007/978-1-4419-6612-4_43.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y et al. JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. J Clin Invest. 2018;128(7):3041–3052. https://doi.org/10.1172/JCI98814.</mixed-citation><mixed-citation xml:lang="en">Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y et al. JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. J Clin Invest. 2018;128(7):3041–3052. https://doi.org/10.1172/JCI98814.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Shendi HM, Devlin LA, Edgar JD. Interleukin 6 blockade for hyperimmunoglobulin D and periodic fever syndrome. J Clin Rheumatol. 2014;20(2):103–105. https://doi.org/10.1097/01.RHU.0000442576.41537.de.</mixed-citation><mixed-citation xml:lang="en">Shendi HM, Devlin LA, Edgar JD. Interleukin 6 blockade for hyperimmunoglobulin D and periodic fever syndrome. J Clin Rheumatol. 2014;20(2):103–105. https://doi.org/10.1097/01.RHU.0000442576.41537.de.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kaplan E, Mukamel M, Barash J, Brik R, Padeh S, Berkun Y et al. Protracted febrile myalgia in children and young adults with familial mediterranean fever: analysis of 15 patients and suggested criteria for working diagnosis. Clin Exp Rheumatol. 2007;25(4):114–117. Available at: https://pubmed.ncbi.nlm.nih.gov/17949564.</mixed-citation><mixed-citation xml:lang="en">Kaplan E, Mukamel M, Barash J, Brik R, Padeh S, Berkun Y et al. Protracted febrile myalgia in children and young adults with familial mediterranean fever: analysis of 15 patients and suggested criteria for working diagnosis. Clin Exp Rheumatol. 2007;25(4):114–117. Available at: https://pubmed.ncbi.nlm.nih.gov/17949564.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Морозова ТЕ, Андрущишина ТБ, Антипова ЕК. Ибупрофен: безопасность и эффективность применения в широкой клинической практике. Терапевтический архив. 2013;85(3):118–124. Режим доступа: https://www.mediasphera.ru/issues/terapevticheskij-arkhiv/2013/3/030040-36602013322.</mixed-citation><mixed-citation xml:lang="en">Morozova TE, Andrushchishina TB, Antipova EK. Ibuprofen: safety and efficiency of its use in wide clinical practice. Terapevticheskii Arkhiv. 2013;85(3):118–124. (In Russ.) Available at: https://www.mediasphera.ru/issues/terapevticheskijarkhiv/2013/3/030040-36602013322.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
